| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |